首页|泮托拉唑和奥美拉唑预防术后应激性溃疡的疗效对比分析

泮托拉唑和奥美拉唑预防术后应激性溃疡的疗效对比分析

扫码查看
目的 探讨泮托拉唑和奥美拉唑预防术后应激性溃疡的疗效.方法 将医院2015年12月~2016年12月200例腹部手术患者按照随机数字表法分组为对照组(泮托拉唑)与观察组(奥美拉唑),分别100例.统计2组应激性溃疡发生率及不良反应,并计算2组成本-效果.结果 观察组应激性溃疡发生率4.0%(4/100)与对照组5.0%(5/100)比较差异无统计学意义(χ2=0.11,P=0.73);观察组成本-效果比与对照组比较差异无统计学意义;2组治疗期间均进行肝肾功能及血常规等检查,未见明显异常,且治疗期间无明显不良反应.结论 腹部手术患者应用泮托拉唑和奥美拉唑可有效预防患者术后应激性溃疡,成本方面无明显差异,无明显不良反应.
Comparison of pantoprazole and omeprazole in the prevention of postoperative stress ulcer
Objective To investigate the efficacy of pantoprazole and omeprazole in the prevention of postoperative stress ulcer.MethodsThe patients were divided into control group (pantoprazole) and observation group (omeprazole) according to the random number table method from December 2015 to December 2016 in 200 cases of abdominal surgery.The incidence and adverse effects of stress ulcer were measured and the cost and effect were calculated.ResultsIn the observation group, the incidence of stress ulcer was 4.0% (4/100) in the observation group compared with 5.0% (5/100) in the control group(χ2=0.11, P=0.73).Compared with the control group, Both groups were treated with liver and kidney function and blood routine examination, no obvious abnormalities, and no significant adverse reactions during treatment.ConclusionAbdominal surgery patients with pantoprazole and omeprazole can effectively prevent postoperative stress ulcers, the cost of no significant difference, no significant adverse reactions.

pantoprazoleomeprazoleabdominal surgerystress ulcer

王琴、吴鹏凌、楼珍燕

展开 >

浙江省义乌市第二人民医院 外科病区,浙江 义乌 322002

泮托拉唑 奥美拉唑 腹部手术 应激性溃疡

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(6)
  • 5
  • 14